Zihua Zeng

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy”.

Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy

Cancers(2020)10.3390/cancers12040780

N/A

0DataRank · unranked

27 citations

Ching‐Hsuan Tung, Youli Zu, Zihua Zeng

Recombinant expression, characterization, and quantification in human cancer cell lines of the Anaplastic Large-Cell Lymphoma-characteristic NPM-ALK fusion protein

Scientific Reports(2020)10.1038/s41598-020-61936-w

N/A

0DataRank · unranked

4 citations

Mary Crum, Ujwal Patil, Ana Prebisch, Dimple Chavan, Binh Vu +5 more

MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma

Nature Communications(2022)10.1038/s41467-022-31331-2

N/A

0DataRank · unranked

76 citations

Mahmoud A. Mohammad, Giorgio Milazzo, Myrthala Moreno‐Smith, Tajhal D. Patel, Barry Zorman +15 more

Aptamer-armed nanostructures improve the chemotherapy outcome of triple-negative breast cancer

Molecular Therapy(2022)10.1016/j.ymthe.2022.02.004

N/A

0DataRank · unranked

24 citations

Zihua Zeng, Jianjun Qi, Zhenghu Chen, Xiaohui Liu, Youli Zu +1 more

Lateral flow assay-based detection of nuclear fusion oncoprotein: implications for screening of acute promyelocytic leukemia

Sensors & Diagnostics(2025)10.1039/d4sd00357h

N/A

0DataRank · unranked

1 citations

Binh Vu, Kristen Brosamer, Sophia Song, Vijay Maranholkar, Zihua Zeng +6 more